Brooke Ligon

Member, Scientific Advisory Board at Diamyd Medical AB

Brooke Ligon

Brooke Ligon

Member, Scientific Advisory Board at Diamyd Medical AB

Biography

Dr. Brooke Ligon
Mitokine Bioscience LLC, Hancock, Maine, USA.

Dr. Ligon received her medical degree from the University of Arkansas for Medical Sciences in the United States She trained as a Neurologist at Tufts Medical Center in Boston and also completed her Ph.D. in Neuroscience there. Dr. Ligon has dedicated her research career to demonstrating the critical role GABA plays in maintaining glucose homeostasis. Her basic and clinical science has revealed that restoring GABA is crucial, in the setting of diabetes, to regenerate beta cells, eliminate the immune pathology and restore long-term health. Dr. Ligon has been a member of the Scientific and Medical Advisory Board since 2013.

Overview
RelSci Relationships

20

Number of Boards

1

Relationships
RelSci Relationships are individuals Brooke Ligon likely has professional access to. A relationship does not necessarily indicate a personal connection.

President & Chief Executive Officer at Diamyd Medical AB

Relationship likelihood: Average

Member, Scientific Advisory Board at Diamyd Medical AB

Relationship likelihood: Average

Member, Scientific Advisory Board at Diamyd Medical AB

Relationship likelihood: Average

Member, Scientific Advisory Board at Diamyd Medical AB

Relationship likelihood: Average

Member, Scientific Advisory Board at Diamyd Medical AB

Relationship likelihood: Average

Member, Scientific Advisory Board at Diamyd Medical AB

Relationship likelihood: Average

Director, Business Development at NextCell Pharma AB

Relationship likelihood: Average

Chairman at Blasieholmen Investment Group Seed AB

Relationship likelihood: Average

Chief Executive Officer at Essen-Möller Consulting

Relationship likelihood: Average

Professor, Department of Medicine at University of California, Los Angeles - David Geffen School of Medicine

Relationship likelihood: Average

Paths to Brooke Ligon
Potential Connections via
Relationship Science
You
Brooke Ligon
Member, Scientific Advisory Board at Diamyd Medical AB
Boards & Committees
Member, Scientific Advisory Board
Current

Diamyd Medical AB engages in the development of pharmaceutical products for the treatment of diabetes and other serious inflammatory diseases. Its pipeline includes Diamyd and Remygen which targets the underlying causes of diabetes, dysfunction, and loss of the pancreatic beta cells. It also develops and invests in stem cell and medical technology. The company was founded by Anders Essen-Moller in 1996 and is headquartered in Stockholm, Sweden.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Brooke Ligon. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Brooke Ligon's profile does not indicate a business or promotional relationship of any kind between RelSci and Brooke Ligon.